AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 222 min read$ATEX

Lang Scott A. sold $14K of ATEX

Lang Scott A. (President and CEO) sold 170 shares of Anterix Inc. (ATEX) at $80.25 on 2026-06-18.

Original reporting
SEC EDGAR · Lang Scott A.
Published Jun 22, 2026, 8:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 22, 2026, 8:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ATEX
Neutral
high confidence
Mentioned
$ATEX
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATEXNeutralLow
01

Why it matters

The CEO’s open-market sale is a new, primary-source datapoint but does not include any fundamental corporate event.

02

Market read

Traders may monitor for follow-on insider activity, but this filing alone is unlikely to drive repricing.

03

What to watch

The sale size is small relative to typical insider holdings; without context on total compensation/tax needs, signal quality is limited.

Relevance 3/10Novelty 3/10Timing: Filed 2026-06-22 for a sale executed 2026-06-18.

Background

The article is a Form 4 insider transaction disclosure for Anterix Inc. (ATEX).

Company-level read

Ticker impact

$ATEXNeutralHigh confidence
Context

Anterix CEO Lang Scott sold 170 shares in an open-market transaction at $80.25 on 2026-06-18, disclosed via Form 4.

Expected impact

Low near-term impact; any effect is likely absorbed unless follow-on selling accelerates.

Evidence & confidence

The filing is a small, single-tranche open-market sale with no 10b5-1 plan and no accompanying fundamental disclosure (no guidance, deal, or enforcement action).

Market effects

Sector

Minimal—this is company-specific insider activity with no sector-wide regulatory or operational change.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Absence of a 10b5-1 plan could be interpreted as discretionary selling, which some traders may read as caution.

Key entities

  • public_company
    Anterix Inc.

    Issuer of the Form 4 insider transaction; ticker ATEX.

  • insider
    Lang Scott A.

    President and CEO; sold 170 shares at $80.25 on 2026-06-18.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ATEX insider trading history →

Related articles

SEP 7
$ATEXMed

Is Anterix (ATEX) Quietly Reframing Its Connectivity Moat With New 900 MHz FCC Flexibility?

Anterix (ATEX) gained attention after the FCC approved expanded 900 MHz broadband use and granted it a license for satellite testing. This could broaden its network applications and reinforce its investment narrative, though profitability currently relies heavily on noncash spectrum gains. Analysts project $6.9M revenue and $935K earnings by 2028, with a potential 36% downside from current prices.

simplywall.st2 min
AUG 19
$ATEXMed

Anterix (ATEX) Q1 2027 Earnings Call Transcript

Anterix (ATEX) reported Q1 2027 revenue of $2M, up from $1.4M YoY, with net income of $240K. Operating expenses decreased to $12.9M. The company has $116M in cash, no debt, and $226.7M left for share repurchases. Management highlighted 12 active deals, spectrum clearing progress, and support for SpaceX's FCC proposal. CFO warned of potential higher costs if spectrum clearing is accelerated.

fool.com4 min
AUG 11
$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Anterix Inc. Reports First Quarter Fiscal Year 2027 Results Woodland Park, NJ – August 11, 2026 – Anterix (NASDAQ: ATEX) today announced its first quarter fiscal 2027 results and filed its Form 10-Q for the three months ended June 30, 2026. Financial and Operational Highlights –

SEC EDGAR 8-K6 min
JUN 10
$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 atex-20260331xpressrelease.htm EX-99.1 Document Anterix Inc. Reports Full Fiscal Year 2026 Results Woodland Park, NJ – June 10, 2026 – Anterix (NASDAQ: ATEX) today announced fiscal 2026 fourth quarter and full fiscal year financial results for the year ended March 31, 2

SEC EDGAR 8-K6 min